LGC expands in Cambridgeshire
LGC, a leading international tools and solutions provider for the life sciences industry, is expanding its bioanalytical and CMC analytical services capacity at its site in Fordham, Cambridgeshire.
In order to meet customer demand LGC has embarked on a three-year development plan.
The first phase began in July 2017 and has just been completed, with the addition of 170m2 new laboratories for large molecule bioanalysis. Further stages involve the expansion of LGC’s other scientific based services and products in the pharmaceutical sector to build a world-leading capability for the benefit of its growing customer base.
Overall, the expansion plan anticipates a 50 per cent increase of laboratories and office space, as well as increasing the number of employees by over 100.
Dr Derek Craston, chief scientific officer, LGC, said: “We’re really excited about the development and expansion of our Fordham site. This investment will initially support our large molecule bioanalysis business and is part of our ongoing plan to take advantage of our strong analytical capabilities and help us address the needs of customers around the world.
“By investing in this area of our business LGC is very much reinforcing our core vision of ‘Science for a safer world’, and our customers will benefit from integrated analytical and manufacturing solutions spanning lead discovery through to the clinic and beyond.”
LGC is an international leader in the extended life sciences sector, including human healthcare, agri-food & the environment. It provides a comprehensive range of reference materials, proficiency testing schemes, genomics reagents and instrumentation, as well as research and measurement services.
Its scientific tools and solutions enable organisations to advance research, develop new products and form an essential part of their quality and compliance procedures.
LGC’s 2,300 employees include internationally-recognised scientists who are experts in their field. Headquartered in London, it operates out of 19 countries worldwide and is extensively accredited to all major quality standards.
LGC has been home to the UK Government Chemist for more than 100 years and is the UK National Measurement Laboratory and Designated Institute for chemical and bio measurement.
The company has been privately-owned since 1996 and has diversified through internal investment and acquisition to be an international leader in its chosen niche markets. LGC is now owned by funds affiliated with KKR.
• PHOTOGRAPH SHOWS: Dr Derek Craston at the LGC Bioanalysis Lab